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Background:  Sudden cardiac death in patients is predominantly caused by ventricular tachycardia (VT)/ventricular fibrillation (VF). Patients who 
have a low left ventricular ejection fraction (LVEF) and inducible VT during electrophysiologic study (EPS) are at risk of sudden death and may benefit 
from an implantable cardioverter-defibrillator (ICD) as do patients with low LVEF. However, LVEF’s primacy in predicted SCD has been questioned. 
Recently, cardiac MRI (CMR) has shown that a determination of myocardial core scar via late gadolinium enhancement (LGE) may predict VT/VF 
with greater precision than LVEF presumably due its ability to define likely sources of macro-rentry by delinieating the ‘gray-zone’ myocardium. We 
hypothesize that LGE depiction of gray-zone scar is more predictive of VT/VF than LGE core scar assessment.
Methods:  A consecutive, retrospective chart review was performed of patients with both a CMR exam for LGE and with post-CMR ICD implantation 
from 2006-2010 within 30 days. Demographic and clinical events were collected from patient charts and ICD interrogation. Standard LGE (>2SD) 
and gray-zone (LGE;2-3SD) was manually determined and related as a percent of LV mass to arrhythmic events and ICD therapy.
Results:  A total of 45 subjects met our inclusion criteria. These included patients with both ischemic (n=28) and non-ischemic (n=17) 
cardiomyopathy. In this population, LVEF was not predictive of ICD therapy in univariate or multivariate analysis (p=NS). In contrast, LGE strongly 
predicted future ICD therapy (combined anti-tachycardia pacing and defibrillation) in the multivariate logistic model (p=0.02), as well as 
defibrillation alone (p=0.03). LGE gray zone showed a similar trend for defibrillation but did not reach statistical significance (p=0.06).
Conclusions:  LGE via CMR is markedly predictive for future ICD therapy delivery in patients with non-ischemic and ischemic cardiomyopathy alike. 
This marker may prove to be an important stratification variable that will greatly enhance current approaches that have traditionally relied soley on 
LVEF.
